PHR3041 Comprehensive care: Blood, brain and cancers
Faculty of Pharmacy and Pharmaceutical Sciences
PHR3041 Comprehensive care: Blood, brain and cancers is a level 3, 12-credit-point, undergraduate unit from the Faculty of Pharmacy and Pharmaceutical Sciences, offered in 2026 in Semester 1 at Malaysia and Parkville. It needs PHR1222, PHR1122, PHR1011, PHR1021, PHR1012, PHR2041, PHR2142, PHR2011, PHR2141, PHR1022, PHR2012, PHR1031, PHR2021 and PHR2042 and unlocks 9 units.
- Credit points
- 12
- Offered in 2026
- Semester 1
- Malaysia, Parkville
- Assessment
- Exam 50%
- and 7 other tasks
This is the 2026 handbook entry. See the 2027 entry.
Reviews
No reviews yetNo reviews yet. Be the first to review PHR3041.
Requisites
Before PHR3041
Prerequisites
Pass these before you enrol.
- PHR1222 How medicines work 4: Medicinal chemistryNo reviews yet
- PHR1122How medicines work 3: PharmacologyNo reviews yet
- PHR1011Professional practice 1No reviews yet
- PHR1021How medicines work 1: Physical chemistryNo reviews yet
- PHR1012Professional practice 2No reviews yet
- PHR2041Comprehensive care: Respiratory and gastrointestinalNo reviews yet
- PHR2142Comprehensive care: CardiovascularNo reviews yet
- PHR2011Professional practice 3No reviews yet
- PHR2141Comprehensive care: Dermatology and painNo reviews yet
- PHR1022How medicines work 2: Pharmacokinetics No reviews yet
- PHR2012Professional practice 4No reviews yet
- PHR1031How the body worksNo reviews yet
- PHR2021How medicines work 5: Drug deliveryNo reviews yet
- PHR2042Comprehensive care: Endocrinology and renalNo reviews yet
After PHR3041
9 units list PHR3041 as a prerequisite or corequisite.
- PHR1101Bridge to practice 2No reviews yetCoreq
- PHR3042Acute care: Inquiry casesNo reviews yet
- PHR3062Student experiential placements 1No reviews yet
- PHR4012Professional practice 5No reviews yet
- PHR4042Integrated careNo reviews yet
- PHR4061Student experiential placements 2No reviews yet
- PHR5052Inquiry and innovation methodsNo reviews yet
- PHR5151Inquiry and innovation projectsNo reviews yet
Overview
This unit provides the knowledge and skills required for the therapeutic management of patients with selected blood and brain conditions as well as cancers. Specifically, the unit will cover conditions involving the brain such as depression and schizophrenia, conditions affecting blood such as anaemias, and cancers such as leukaemia and lung cancer. You will relate the pathophysiology and epidemiology of these conditions to the rational design and clinical use of medicines. The pharmacology, disposition, and clinical and therapeutic aspects of medicines associated with each condition will be presented in an integrated fashion. This unit will involve the development of pharmacy relevant skills such as critical thinking and oral and written communication skills. Quality use of medicines principles will be emphasised, enabling you to acquire the skills necessary to optimise patient outcomes in different cultural settings.
Offerings in 2026
| Teaching period | Campus | Mode |
|---|---|---|
| First semester | Malaysia | On campus |
| First semester | Parkville | Blended |
Assessment
- Individual Readiness Assurance testsQuiz / Test5%
- MyPharm engagementPortfolio5%
- Workshop case-based assessment 1Demonstration5%
- Workshop case-based assessment 2Demonstration5%
- Workshop case-based assessment 3Demonstration5%
- Mid semester testQuiz / Test15%
- Workshop case-based assessment 4Demonstration10%
- Final examinationExaminationCompetency hurdle50%
Assessment details may change. Please refer to the assessment information in Moodle closer to the start of the teaching period.
Learning outcomes
When you finish this unit, you should be able to:
- 1
Describe the pathophysiology, epidemiology and clinical aspects of disease state management of selected blood and brain conditions, and cancers
- 2
Interpret the signs and symptoms, and laboratory parameters associated with a range of blood and brain conditions, and cancers
- 3
Explain the molecular basis of drug action and/or the mechanism of action of drugs used in treatment of selected blood and brain conditions, and cancers, and predict therapeutic outcomes and potential adverse effects based on pharmacodynamic and pharmacokinetic principles
- 4
In the context of a pharmacist and a standardised approach to patient centred care (e.g. Monash Model of CARE) in patients' with a blood or brain condition and/or cancer:
(i) Gather and integrate information concerning the pharmacology pharmacokinetic characteristics of medicines, clinical aspects of disease state
management, and patient specific factors to identify and appraise potential management options
(ii) Create a medication management plan which incorporates established clinical guidelines and a comprehensive clinical review of medicine-related problems
(iii) Prioritise and rationalise drug and non-drug therapy options for condition management
(iv) Evaluate clinical scenarios to determine when medical referral is necessary, particularly for symptoms indicating urgent care
(v) Create, apply and communicate education strategies that provide support and optimise patient-centred relationships and outcomes - 5
Reflect on the development and implementation of the Monash model of CARE plan and other key skills relevant to pharmacy practice.
- 6
Demonstrate effective collaboration within a multidisciplinary healthcare team to develop and articulate evidence-based clinical and communication strategies for the management of selected blood and brain conditions, and cancers.
- 7
Demonstrate an integrated understanding of key concepts from previous professional practice and comprehensive care topics, promoting a holistic approach to patient care.
Workload and teaching
- Applied sessions59 hours
- Workshops36 hours
- Assessments3 hours
- Teaching approachActive learning
- One hundred and forty-four hours of independent study
- Forty-eight hours of pre-learning activities (up to 4 hours per week)
- Fifty-nine hours of active learning applied sessions (4 hours a week)
- Thirty-nine hours of small group classes including assessment (4 hours per week)
- Three 1-hour skills coaching sessions
Learning resources
Required resources
UptoDate: Evidence-based Clinical Decision Support
MIMS Online
Australian Medicines handbook (AMH)
Therapeutic guidelines
Recommended resources
Pharmacology for Health Professionals, 4th edition, 2014 - Optional
Rang, Dale, Ritter and Flower; Rang and Dale’s Pharmacology, 8th edition, 2016
Australian Pharmaceutical Formulary (APF)
Contacts
- Chief Examiners
- Associate Professor Daniel Malone
- Unit Coordinators
- Associate Professor Daniel Malone
- Dr Yen Jun Wong
Common questions
What are the prerequisites for PHR3041?
You need PHR1222, PHR1122, PHR1011, PHR1021, PHR1012, PHR2041, PHR2142, PHR2011, PHR2141, PHR1022, PHR2012, PHR1031, PHR2021 and PHR2042 before you enrol.
What can I take after PHR3041?
PHR3041 is a prerequisite or corequisite for 9 units, including PHR1101, PHR3042, PHR3062, PHR4012, PHR4042 and PHR4061.
When is PHR3041 offered?
In 2026, PHR3041 runs in Semester 1 at Malaysia and Parkville.
Does PHR3041 have an exam?
Yes. The exam is worth 50% of the final mark, alongside 7 other tasks.